CNS gene delivery by retrograde transport of recombinant replication-defective adenoviruses.

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Gene Therapy

• Publication date

  1995-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 7536617
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Rabies pathogenesis

  2005cited by this paper
• Efficient catheter-mediated gene transfer into the heart using replication-defective adenovirus.

  1994cited by this paper
• Ablation of E2A in recombinant adenoviruses improves transgene persistence and decreases inflammatory response in mouse liver.

  1994cited by this paper
• Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy.

  1994cited by this paper
• An adenovirus vector for gene transfer into neurons and glia in the brain

  1993cited by this paper
• Adenoviral Vector as a Gene Delivery System into Cultured Rat Neuronal and Glial Cells

  1993cited by this paper
• Adenovirus vectors enter the brain.

  1993cited by this paper
• Superoxide Dismutase Activity, Oxidative Damage, and Mitochondrial Energy Metabolism in Familial and Sporadic Amyotrophic Lateral Sclerosis

  1993cited by this paper
• Transfer of a foreign gene into the brain using adenovirus vectors

  1993cited by this paper
• Gene delivery into the brain using virus vectors

  1993cited by this paper
• Long–term correction of mouse dystrophic degeneration by adenovirus–mediated transfer of a minidystrophin gene

  1993cited by this paper
• A model system for in vivo gene transfer into the central nervous system using an adenoviral vector

  1993cited by this paper
• Direct in vivo gene transfer to ependymal cells in the central nervous system using recombinant adenovirus vectors

  1993cited by this paper
• Gene delivery to spinal motor neurons.

  1993cited by this paper
• Amyotrophic lateral sclerosis and structural defects in Cu,Zn superoxide dismutase.

  1993cited by this paper
• Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis.

  1993cited by this paper
• Adenovirus as an expression vector in muscle cells in vivo.

  1992cited by this paper
• Viral persistence in neurons explained by lack of major histocompatibility class I expression.

  1991cited by this paper
• A latent, nonpathogenic HSV-1-derived vector stably expresses beta-galactosidase in mouse neurons.

  1990cited by this paper
• Viruses as transneuronal tracers.

  1990cited by this paper
• Expression of recombinant genes in myocardium in vivo after direct injection of DNA.

  1990cited by this paper
• Structure and expression of the murine slow/cardiac troponin C gene.

  1989cited by this paper
• Transsynaptic retrograde transport of fragment C of tetanus toxin demonstrated by immunohistochemical localization.

  1986cited by this paper
• Cytoarchitecture of the extranuclear and commissural dendrites of hypoglossal nucleus neurons as revealed by conjugates of horseradish peroxidase with cholera toxin.

  1982cited by this paper
• Selective binding, uptake, and retrograde transport of tetanus toxin by nerve terminals in the rat iris. An electron microscope study using colloidal gold as a tracer

  1978cited by this paper
• Entry of peroxidase into neurons of the central and peripheral nervous systems from extracerebral and cerebral blood

  1976cited by this paper
• Tetanus toxin: direct evidence for retrograde intraaxonal transport.

  1975cited by this paper
• Immunization by selective infection with type 4 adenovirus grown in human diploid tissue cultures. I. Safety and lack of oncogenicity and tests for potency in volunteers.

  1966cited by this paper
• An inherited disease similar to amyotrophic lateral sclerosis with a pattern of posterior column involvement. An intermediate form?

  1959cited by this paper

• Gene Therapy Approach with an Emphasis on Growth Factors: Theoretical and Clinical Outcomes in Neurodegenerative Diseases

  2021cites this paper
• Intramuscular Delivery of Gene Therapy for Targeting the Nervous System

  2020cites this paper
• 12 Gene and Cell Therapy for Peripheral Neuropathy

  2018cites this paper
• Alleviation of Trigeminal Nociception Using p75 Neurotrophin Receptor Targeted Lentiviral Interference Therapy

  2018cites this paper
• Gene Therapy for Spinal Cord Injury

  2016cites this paper
• NGF and BDNF Gene Therapy for Alzheimer’s Disease

  2016cites this paper
• Targeting Motor End Plates for Delivery of Adenoviruses: An Approach to Maximize Uptake and Transduction of Spinal Cord Motor Neurons

  2016cites this paper
• Low-Affinity Neurotrophin Receptor p75 Promotes the Transduction of Targeted Lentiviral Vectors to Cholinergic Neurons of Rat Basal Forebrain

  2016cites this paper
• A reduction in the human adenovirus virion size through use of a shortened fibre protein does not enhance muscle transduction following systemic or localised delivery in mice.

  2014cites this paper
• Enhancement of Photoelectrocatalysis Efficiency by Using Nanostructured Electrodes

  2014cites this paper
• Neurotoxicity and Neuroprotection in Spinal Cord Injury

  2014cites this paper
• Animal Models of Spinal Cord Injury

  2013cites this paper
• Gene and Cell Therapy for Peripheral Neuropathy

  2012cites this paper
• Gene therapy approaches to enhancing plasticity and regeneration after spinal cord injury.

  2012cites this paper
• pUNISHER: a high-level expression cassette for use with recombinant viral vectors for rapid and long term in vivo neuronal expression in the CNS.

  2011cites this paper
• A novel neurotropic expression vector based on the avirulent A7(74) strain of Semliki Forest virus

  2011cites this paper
• Innocuous full-length botulinum neurotoxin targets and promotes the expression of lentiviral vectors in central and autonomic neurons

  2011cites this paper
• Gene Therapy: A Potential Approach for Cancer Pain

  2011cites this paper
• Gene therapy for the peripheral nervous system: a strategy to repair the injured nerve?

  2011cites this paper
• Enhanced adenoviral gene delivery to motor and dorsal root ganglion neurons following injection into demyelinated peripheral nerves

  2010influential citation
• Recombinant adeno-associated virus serotype 6 (rAAV2/6)-mediated gene transfer to nociceptive neurons through different routes of delivery

  2009cites this paper
• Engineered adenovirus serotypes for overcoming anti-vector immunity

  2009cites this paper
• Gene Therapy for Cystic Fibrosis

  2008cites this paper
• Subcutaneous peripheral injection of cationized gelatin/DNA polyplexes as a platform for non-viral gene transfer to sensory neurons.

  2007cites this paper
• Gene therapy for peripheral nervous system diseases.

  2007cites this paper
• Développement de vecteurs lentiviraux régulables pour le transfert de gène dans le système nerveux central

  2007cites this paper
• Development and characterisation of an experimental recurrent laryngeal nerve injury model for the study of viral gene therapy

  2007cites this paper
• Atraumatic Oral Spray Immunization with Replication-Deficient Viral Vector Vaccines

  2007cites this paper
• Conditional NF-L Transgene Expression in Mice for In Vivo Analysis of Turnover and Transport Rate of Neurofilaments

  2007cites this paper
• Transduction of brain by herpes simplex virus vectors.

  2007cites this paper
• Gene Therapy to the Nervous System

  2006cites this paper
• CHAPTER 20 – Viral Vector Axonal Uptake and Retrograde Transport: Mechanisms and Applications

  2006cites this paper
• Transduction of motor neurons and muscle fibers by intramuscular injection of HIV-1-based vectors pseudotyped with select rabies virus glycoproteins.

  2006cites this paper
• Adenoviral GDNF gene transfer enhances neurofunctional recovery after recurrent laryngeal nerve injury

  2006cites this paper
• Adenoviral interneuronal transportation after retrograde gene transfer in mice.

  2005cites this paper
• AAV for disorders of the CNS

  2005cites this paper
• Cellular and Gene Therapy Approaches to Spinal Cord Injury

  2005cites this paper
• Adeno‐associated viral vectors for gene therapy

  2005cites this paper
• Peripheral nerve avulsion injuries as experimental models for adult motoneuron degeneration

  2005cites this paper
• Axonal transport of recombinant baculovirus vectors.

  2004cites this paper
• Transduction patterns of pseudotyped lentiviral vectors in the nervous system.

  2004cites this paper
• Inhibition of mixed lineage kinase 3 attenuates MPP+-induced neurotoxicity in SH-SY5Y cells.

  2004cites this paper
• In vivo somatic delivery of plasmid DNA and retrograde transport to obtain cell‐specific gene expression in the central nervous system

  2004cites this paper
• Cytoplasmic Dynein Mediates Adenovirus Binding to Microtubules

  2004cites this paper
• Physiological genomic analysis of the brain renin-angiotensin system.

  2003cites this paper
• Delivery of an Adenoviral Vector to the Crushed Recurrent Laryngeal Nerve

  2003influential citation
• Potential of gene therapy for pediatric neurotransmitter diseases: Lessons from Parkinson's disease

  2003cites this paper
• Gene Transfer into the Central and Peripheral Nervous System: Applications for the Treatment of Neurodegenerative Diseases and Peripheral Neuropathies

  2003cites this paper
• Neurotrophic factors expressed in both cortex and spinal cord induce axonal plasticity after spinal cord injury

  2003cites this paper
• Intraneural Colchicine Inhibition of Adenoviral and Adeno-associated Viral Vector Remote Spinal Cord Gene Delivery

  2003cites this paper
• Molecular biology and gene therapy in the treatment of chronic pain.

  2003cites this paper
• Adenoviral Retrograde Gene Transfer in Motoneurons Is Greatly Enhanced by Prior Intramuscular Inoculation with Botulinum Toxin

  2002cites this paper
• Selective Gene Transfer to Key Cardiovascular Regions of the Brain: Comparison of Two Viral Vector Systems

  2002cites this paper
• Targeting functional subtypes of spinal motoneurons and skeletal muscle fibers in vivo by intramuscular injection of adenoviral and adeno-associated viral vectors

  2002cites this paper
• Viral-mediated gene transfer to mouse primary neural progenitor cells.

  2002cites this paper
• Neuronal survival following remote adenovirus gene delivery.

  2002cites this paper
• Increased Survival and Function of SOD1 Mice After Glial Cell-Derived Neurotrophic Factor Gene Therapy

  2002cites this paper
• Preferential transduction of neurons by canine adenovirus vectors and their efficient retrograde transport in vivo

  2001cites this paper
• Remote Delivery of rAAV‐GFP to the Rat Brainstem Through the Recurrent Laryngeal Nerve

  2001cites this paper
• Continuous Delivery of Neurotrophin 3 by Gene Therapy Has a Neuroprotective Effect in Experimental Models of Diabetic and Acrylamide Neuropathies

  2001cites this paper
• Gene therapy strategies in neurodegenerative diseases.

  2001cites this paper
• Transgene expression in the brain stem effected by intramuscular injection of polyethylenimine/DNA complexes.

  2001cites this paper
• Rabies virus glycoprotein pseudotyping of lentiviral vectors enables retrograde axonal transport and access to the nervous system after peripheral delivery.

  2001cites this paper
• Adenovirus-mediated gene delivery to cells of the magnocellular hypothalamo-neurohypophyseal system.

  2001cites this paper
• Gene Therapy for Cerebrovascular Disease and Central Nervous System Trauma

  2001cites this paper
• Synaptic sprouting increases the uptake capacities of motoneurons in amyotrophic lateral sclerosis mice

  2001cites this paper
• Effect of immunity on gene delivery into anterior horn motor neurons by live attenuated herpes simplex virus vector

  2001cites this paper
• Gene therapy for central nervous system repair.

  2001cites this paper
• Gene Therapy for the Management of Pain: Part I: Methods and Strategies

  2001cites this paper
• Production and neurotropism of lentivirus vectors pseudotyped with lyssavirus envelope glycoproteins.

  2001cites this paper
• Regulatable and cell-type specific transgene expression in glial cells: prospects for gene therapy for neurological disorders.

  2001cites this paper
• Gene therapy strategies in neurodegenerative diseases.

  2001cites this paper
• Impaired retrograde axonal transport of adenovirus-mediated E. coli LacZ gene in the mice carrying mutant SOD1 gene.

  2001cites this paper
• Circumventricular Organs: Gateways to the Brain Approaches For Gene Delivery To The Subfornical Organ And Magnocellular Neurons

  2001cites this paper
• Bcl-2 expression by retrograde transport of adenoviral vectors with Cre-loxP recombination system in motor neurons of mutant SOD1 transgenic mice

  2001cites this paper
• Gene Therapy for Amyotrophic Lateral Sclerosis and Other Motor Neuron Diseases

  2000cites this paper
• Partial functional recovery of paraplegic rat by adenovirus-mediated gene delivery of constitutively active MEK1.

  2000cites this paper
• Canine models for human genetic neurodegenerative diseases.

  2000cites this paper
• Retargeting of adenoviral vectors to neurons using the HC fragment of tetanus toxin

  2000cites this paper
• Rescue of lesioned adult rat spinal motoneurons by adenoviral gene transfer of glial cell line‐derived neurotrophic factor

  2000influential citation
• Long-term gene expression in the anterior horn motor neurons after intramuscular inoculation of a live herpes simplex virus vector

  2000cites this paper
• Protection by Synergistic Effects of Adenovirus-Mediated X-Chromosome-Linked Inhibitor of Apoptosis and Glial Cell Line-Derived Neurotrophic Factor Gene Transfer in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Model of Parkinson's Disease

  2000cites this paper
• Uptake of circulating insulin‐like growth factor‐I into the cerebrospinal fluid of normal and diabetic rats and normalization of IGF‐II mRNA content in diabetic rat brain

  2000cites this paper
• Adenoviral and adeno-associated viral transfer of genes to the peripheral nervous system.

  2000cites this paper
• Charcot-Marie-Tooth disease type 1: molecular pathogenesis to gene therapy.

  2000cites this paper
• Neuron-restrictive silencer elements mediate neuron specificity of adenoviral gene expression

  1999cites this paper
• Strategies for Administering Neurotrophic Factors to the Central Nervous System

  1999cites this paper
• Chapter 3.2.2 Adenovirus vectors for gene transfer into the central nervous system

  1999cites this paper
• Gene therapy for cerebrovascular disease.

  1999cites this paper
• Adenovirus-mediated gene delivery to hypothalamic magnocellular neurons in mice.

  1999cites this paper
• Gene therapy for Parkinson's disease: review and update.

  1999cites this paper
• Microtubule-dependent Plus- and Minus End–directed Motilities Are Competing Processes for Nuclear Targeting of Adenovirus

  1999cites this paper
• Therapeutic benefit of ciliary neurotrophic factor in progressive motor neuronopathy depends on the route of delivery

  1999cites this paper
• Adenoviral vectors: prospects for gene delivery to the central nervous system

  1999cites this paper
• Genetic Engineering for CNS Regeneration

  1999cites this paper
• Adenoviral cardiotrophin-1 gene transfer protects pmn mice from progressive motor neuronopathy.

  1999cites this paper
• Adenovirus-Mediated Transgene Expression in Nonhuman Primate Brain

  1999cites this paper
• Adenoviral‐mediated gene transfer to enhance neuronal survival, growth, and regeneration

  1999cites this paper
• Adenovirus in the brain: recent advances of gene therapy for neurodegenerative diseases.

  1998cites this paper
• Expression of adenovirus-mediated E. coli lacZ gene in skeletal muscles and spinal motor neurons of transgenic mice with a mutant superoxide dismutase gene.

  1998cites this paper